🟢 Painreform is trading 5.3% up in pre-market as biotech sector rises 2.61% pre-market

Painreform is trading 5.3% up at $0.98, with broader biotech-sector strength the most likely explanation for the move. - The price compares with the September 22 close of $0.93; no verified company-specific announcement was identified for September 23, 2026. - Recent coverage centers on earlier GridFeed and DeepSolar initiatives; biotechnology was up 2.61% pre-market.